SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-026119
Filing Date
2023-02-27
Accepted
2023-02-27 17:27:25
Documents
16
Period of Report
2023-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm237999d1_8k.htm   iXBRL 8-K 24294
2 EXHIBIT 99.1 tm237999d1_ex99-1.htm EX-99.1 37343
6 GRAPHIC tm237999d1_ex99-1img001.jpg GRAPHIC 4338
7 GRAPHIC tm237999d1_ex99-1img002.jpg GRAPHIC 266155
8 GRAPHIC tm237999d1_ex99-1img003.jpg GRAPHIC 217767
  Complete submission text file 0001104659-23-026119.txt   915637

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qure-20230227.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qure-20230227_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qure-20230227_pre.xml EX-101.PRE 22593
10 EXTRACTED XBRL INSTANCE DOCUMENT tm237999d1_8k_htm.xml XML 3494
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 23676801
SIC: 2834 Pharmaceutical Preparations